BIO Europe Fall 2019

Best Path Forward for Successful Product Development
Tuesday, November 12 | 11:15午前-12:00午後

Moderator: Martin Gouldstone, Global SVP, Syneos One
Andrew Hotchkiss, CCO, Immunocore 
Sean Marett, CBO and COO, BioNTech 
Hartmut Juhl, Founder and CEO, Indivumed Group
Grace Colon, CEO & President, InCarda Therapeutics

Clinical development, product approval, patient compliance, improved outcomes, and a value-based system all depend on innovative, successful product differentiation to address unmet medical needs. This session will explore the use of real-world evidence and other resources that can provide advantages from de-risking drug development to paving the way for positive clinical trials to launching new therapies. Industry experts share their insights on ways to leverage the ever expanding opportunities to use RWE